EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Fournier’s gangrene: evolving understanding and modern management of a necrotising surgical emergency

Jaiden Townsend, Gillian Smith, Georgios Kravvas, Asif Muneer, Christopher Bunker, Michael Dinneen

Clinical and Experimental Dermatology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Fournier’s gangrene (FG) is a rapidly progressive, life-threatening necrotising soft tissue infection of the perineum and external genitalia that remains a surgical emergency with a high mortality despite advances in critical care. Once considered idiopathic, contemporary evidence demonstrates that FG most often arises from identifiable anorectal, urogenital, or cutaneous sources in patients with significant comorbidities, particularly diabetes mellitus and other states of immunocompromise. Mortality remains substantial, typically in the range of 20–30% and is strongly influenced by delays in diagnosis and definitive surgical intervention. This review updates and expands the previous 1998 review (Smith et al.) synthesising recent literature on the epidemiology, pathophysiology, microbiology, clinical presentation, diagnostic principles, management strategies, and outcomes of FG. Emphasis is placed on FG as a primarily clinical diagnosis requiring a high index of suspicion in patients presenting with rapidly progressive perineal pain and infection disproportionate to the physical findings. Prompt and aggressive surgical debridement remains the cornerstone of management, supported by broad-spectrum antimicrobial therapy, intensive supportive care, and a multidisciplinary approach, while the role of adjunctive therapies such as hyperbaric oxygen therapy and negative pressure wound therapy is critically appraised. Despite improvements in recognition and treatment, FG continues to carry significant morbidity and mortality, underscoring the importance of early diagnosis, immediate pathogen control, and coordinated multidisciplinary care to optimise patient outcomes.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Jaiden Townsend, Gillian Smith, Georgios Kravvas, Asif Muneer, Christopher Bunker, Michael Dinneen
Quelle
Clinical and Experimental Dermatology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0307-6938, 1365-2230
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Jaiden Townsend, Gillian Smith, Georgios Kravvas, Asif Muneer, Christopher Bunker, Michael Dinneen (2026). Fournier’s gangrene: evolving understanding and modern management of a necrotising surgical emergency. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag387
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1